* Advance Tissue Synchronization Imaging (TSI) - time-to-peak data derived from TSI's simple-to-use "red light/green light" visualizations to quantify left ventricle synchronicity for heart failure patients or those undergoing cardiac resynchronization therapy (CRT).
* Automated Function Imaging (AFI)- easy-to-use, quick and accurate tool allowing clinicians to assess and quantify left ventricle wall motion.

"AFI is a simple, user-friendly program that allows regional function quantification with minimal input," said Dr. Ted Abraham, Associate Professor of Medicine and Associate Director of the Echocardiography Laboratory at Johns Hopkins University.


With more 4D imaging capabilities than ever before and new quantitative analysis tools, the Vivid 7 Dimension '06 further underscores GE's commitment to cardiovascular ultrasound innovation.

"Vivid 7 Dimension '06 demonstrates our leadership in the industry and underscores our commitment to continuous innovation in Ultrasound," said Omar Ishrak, president and CEO of GE Healthcare's Clinical Systems business. "The impact of easier to use real-time, full volume 4D color imaging on diagnostic confidence, productivity and ultimately, better patient care, combined with the Vivid 7 multi-dimensional imaging capabilities, demonstrates the strength of the Vivid platform today and for the future."

For more information about GE Healthcare, visit www.gehealthcare.com.

Back to HCB News

More Industry Headlines